GlassScriptPhysician profile
Susan Levin
NPI 1932267408
$2,215.29
in general payments reported to CMS, 2019-2025
18 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $339 · 2021: $115 · 2022: $73.34 · 2023: $123 · 2024: $176 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $641.47 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbott Laboratories | $329.71 | 2019-2020 | |
| Novo Nordisk INC | $244.66 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $156.61 | 2019-2021 | |
| Glaxosmithkline, LLC. | $150.21 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Kowa Pharmaceuticals America, INC. | $116.63 | 2019-2023 | Livalo, Seglentis |
| Arbor Pharmaceuticals, INC. | $110.01 | 2019 | |
| Lilly USA, LLC | $109.27 | 2019-2025 | Mounjaro, Zepbound |
| Amgen INC. | $82.18 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $68.80 | 2019-2023 | |
| Exact Sciences Corporation | $45.94 | 2024-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $43.80 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $28.77 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.25 | 2019 | |
| Astellas Pharma US INC | $18.53 | 2024 | Veozah |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $13.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.